Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferaseUffe H. Olesen, Maxwell Sehested, Jakob Gramstrup Petersen et al.|BMC Cancer|2010Cited by 52
Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139Mohamed A. Shehata, David E. Gloriam, Vignir Ísberg et al.|Scientific Reports|2016Cited by 28